National Peroxide Ltd Falls to 52-Week Low Amidst Continued Downtrend

Jan 19 2026 11:18 AM IST
share
Share Via
National Peroxide Ltd’s stock declined sharply to a new 52-week and all-time low of Rs.412.1 on 19 Jan 2026, marking a significant milestone in its ongoing downward trajectory. The stock’s performance continues to lag behind its sector and broader market indices, reflecting persistent pressures on the company’s financial metrics and market sentiment.
National Peroxide Ltd Falls to 52-Week Low Amidst Continued Downtrend



Stock Price Movement and Market Context


On the day in question, National Peroxide Ltd’s share price touched an intraday low of Rs.412.1, representing a 5.44% drop from previous levels. This decline contributed to a two-day consecutive fall, resulting in a cumulative loss of 2.71% over this period. The stock underperformed its sector by 1.5% on the same day, signalling relative weakness within the commodity chemicals space.


Technical indicators further underscore the bearish trend, with the stock trading below all key moving averages — including the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This broad-based technical weakness suggests sustained selling pressure and a lack of short-term momentum.


Meanwhile, the broader market environment was also subdued. The Sensex opened flat but declined by 454.46 points (-0.63%) to close at 83,040.03, marking its third consecutive weekly fall with a cumulative loss of 3.17%. Despite this, the Sensex remains approximately 3.76% below its 52-week high of 86,159.02, indicating that the broader market has not mirrored the steep declines seen in National Peroxide Ltd’s stock.



Financial Performance and Fundamental Concerns


National Peroxide Ltd’s financial fundamentals have been under strain, contributing to the stock’s weak performance. Over the past five years, the company has experienced a compound annual growth rate (CAGR) decline of 135.58% in operating profits, highlighting a significant erosion in core earnings capacity. This deterioration in profitability is reflected in the company’s weak ability to service debt, with an average EBIT to interest coverage ratio of just 0.14, indicating limited cushion to meet interest obligations.


The company’s return on equity (ROE) has averaged a modest 1.90%, signalling low profitability relative to shareholders’ funds. This level of return is considerably below industry norms and suggests challenges in generating value for investors.


Recent results for the six months ended September 2025 showed a decline in profit after tax (PAT) to Rs.1.28 crore, representing a 77.78% decrease compared to the prior period. Notably, non-operating income accounted for 263.49% of profit before tax (PBT), indicating that earnings are increasingly reliant on non-core activities rather than operational performance.




Our latest weekly pick is live! This Large Cap from Diamond & Gold Jewellery comes with clear entry and exit targets. See the detailed report with target price now!



  • - Clear entry/exit targets

  • - Target price revealed

  • - Detailed report available


View Target Price Report →




Valuation and Risk Profile


The stock’s valuation metrics reflect elevated risk levels. Over the past year, National Peroxide Ltd’s share price has declined by 43.93%, a stark contrast to the Sensex’s positive return of 8.39% during the same period. The stock’s 52-week high was Rs.779.9, underscoring the magnitude of the recent price erosion.


Profitability has also deteriorated sharply, with profits falling by 113% over the last year. This combination of declining earnings and share price has resulted in the stock trading at valuations that are considered risky relative to its historical averages.


Longer-term performance has also been below par. The stock has underperformed the BSE500 index over the last three years, one year, and three months, indicating persistent challenges in generating shareholder returns.



Shareholding and Market Grade


Promoters remain the majority shareholders of National Peroxide Ltd, maintaining significant control over the company’s strategic direction. The stock currently holds a Mojo Score of 12.0 and has been assigned a Mojo Grade of Strong Sell as of 7 May 2025, an upgrade from the previous Sell rating. The market capitalisation grade stands at 4, reflecting the company’s relatively modest size within the commodity chemicals sector.




National Peroxide Ltd or something better? Our SwitchER feature analyzes this micro-cap Commodity Chemicals stock and recommends superior alternatives based on fundamentals, momentum, and value!



  • - SwitchER analysis complete

  • - Superior alternatives found

  • - Multi-parameter evaluation


See Smarter Alternatives →




Summary of Key Metrics


To summarise, National Peroxide Ltd’s stock has reached a new low of Rs.412.1, reflecting ongoing pressures from weak financial performance and subdued market conditions. The company’s operating profits have declined significantly over the past five years, with recent earnings showing contraction and reliance on non-operating income. The stock’s valuation and technical indicators point to continued challenges, with the share price trading below all major moving averages and underperforming both its sector and the broader market indices.


While the Sensex has experienced some volatility, it remains well above its 52-week low, contrasting with the steep decline seen in National Peroxide Ltd’s shares. The company’s low return on equity and limited interest coverage ratio further highlight the financial constraints facing the business.



Market Sentiment and Broader Implications


The stock’s downgrade to a Strong Sell grade by MarketsMOJO on 7 May 2025 reflects the cumulative impact of these factors. The Mojo Score of 12.0 underscores the cautious stance adopted by market analysts, given the company’s deteriorating fundamentals and valuation risks. National Peroxide Ltd’s position within the commodity chemicals sector, which itself has faced headwinds, adds to the complexity of its current market standing.


Investors and market participants will continue to monitor the stock’s price movements and financial disclosures closely, as the company navigates this challenging phase marked by subdued earnings and valuation pressures.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News